{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-006720","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.115515+00:00","generated_at":"2026-05-17T01:57:06.876188+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Beta Bionics Q3 sales up 63% YoY to $27.3M; raises full-year 2025 guidance","bullets":["Net sales $27.3M (+63% YoY); DME $21.0M (+45%), PBP $6.2M (+178%).","Gross margin 55.5% (+212 bps); net loss $14.2M vs $9.7M prior year.","Installed base 29,419 users (+162%); new patient starts 5,334 (+68%); 70% from MDI.","Adjusted EBITDA -$12.2M (negative 45% of sales); cash $274.0M.","Raised full-year 2025 guidance; specific numbers not disclosed in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-006720","json":"https://secwatch.observer/filing/0001171843-25-006720.json","markdown":"https://secwatch.observer/filing/0001171843-25-006720.md","text":"https://secwatch.observer/filing/0001171843-25-006720.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325006720/0001171843-25-006720-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325006720/f8k_102825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:57:06.876188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}